| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/31/1994 | EP0612242A1 Methods and compositions utilizing pure s(+) isomer fluoxetine |
| 08/30/1994 | US5342757 Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof |
| 08/24/1994 | EP0611573A2 Bioactive conjugates of cellulose with amino compounds |
| 08/24/1994 | EP0478631B1 Targetting agents |
| 08/24/1994 | CN1091005A Immunopotentiatory agents and physiologically acceptable salts thereof |
| 08/23/1994 | US5340736 ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting |
| 08/23/1994 | US5339766 Method of introducing material into eggs during early embryonic development |
| 08/18/1994 | WO1994018308A1 Novel receptor-type phosphotyrosine phosphatase-beta |
| 08/18/1994 | WO1994017823A1 Vaccine compositions and method for induction of mucosal immune response via systemic vaccination |
| 08/18/1994 | WO1994017816A1 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof |
| 08/18/1994 | WO1994017796A1 Therapeutic use of compounds having selective agonist-like activity on rxr retinoid receptors |
| 08/18/1994 | WO1994017790A1 Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma |
| 08/18/1994 | WO1994017780A1 Waterproof cosmetic or dermatological photoprotective preparations |
| 08/18/1994 | WO1994017779A1 Cosmetic and dermatological photoprotective formulations containing inorganic micro-pigments |
| 08/18/1994 | WO1994011026A3 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 08/18/1994 | CA2155828A1 Therapeutic use of compounds having selective agonist-like activity on rxr retinoid receptors |
| 08/18/1994 | CA2155554A1 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof |
| 08/18/1994 | CA2155545A1 Novel receptor-type phosphotyrosine phosphatase-beta |
| 08/18/1994 | CA2153794A1 Vaccine compositions and method for induction of mucosal immune response via systemic vaccination |
| 08/17/1994 | EP0610926A1 Topical compositions for protection against stinging animals |
| 08/17/1994 | EP0610433A1 Compositions containing k-252 compounds for potentiation of neurotrophin activity |
| 08/17/1994 | EP0610368A1 Treatment of acne or of pseudofolliculitis barbae |
| 08/17/1994 | EP0527720B1 Therapeutic agents |
| 08/16/1994 | US5338744 Angiotensin II antagonists used to treat reproductive functions associated with AT2 receptors |
| 08/16/1994 | US5338663 Interferes with formation of specific complex between alpha-antichymotrypsin and beta-protein; hydrolysis of substrate does not occur |
| 08/16/1994 | CA2115630A1 Bioactive conjugates of cellulose with amino compounds |
| 08/10/1994 | EP0609961A1 Sustained release pharmaceutical composition |
| 08/10/1994 | EP0609701A1 L-cystein, L-cystine or L-glutamine as a supplementary therapeutic agent for the treatment of immunodeficiency syndrome |
| 08/10/1994 | EP0609606A1 Tucaresol as an immunopotentiatory agent |
| 08/10/1994 | EP0436620B1 Matrix with immunomodulating activity |
| 08/09/1994 | US5336675 Administering acetylcholinesterase inhibitor which can pass through blood-brain barrier in humans |
| 08/09/1994 | US5336666 Immunostimulant drug based on polar glyopeptidolipids of mycobacterium chelonae |
| 08/09/1994 | US5336508 Sodium silver chloride |
| 08/09/1994 | US5336488 Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines |
| 08/04/1994 | WO1994017087A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use |
| 08/04/1994 | WO1994017055A1 Antiviral naphthoquinone compounds, compositions and uses thereof |
| 08/04/1994 | WO1994016735A1 Anti-zona pellucida antibodies for delivery of therapeutic agents to the ovary |
| 08/04/1994 | WO1994016731A1 Ganglioside-klh conjugate vaccines with qs-21 |
| 08/04/1994 | WO1994016724A1 Prevention and treatment of cytomegalovirus using aminopeptidase |
| 08/04/1994 | WO1994016697A1 Synergising association having an antagonist effect on nk1 and nk2 receptors |
| 08/04/1994 | WO1994016683A1 Magnetically responsive composition for carrying biologically active substances and methods of production and use |
| 08/04/1994 | WO1994013277A3 Use of dinaphthalenes compounds as antiproliferative agents |
| 08/04/1994 | CA2154882A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use |
| 08/04/1994 | CA2154346A1 Prevention and treatment of cytomegalovirus using aminopeptidase |
| 08/04/1994 | CA2132632A1 Anti-zona pellucida antibodies for delivery of therapeutic agents to the ovary |
| 08/03/1994 | EP0608893A1 Inhibiting the development of tolerance to and/or dependence on an additive substance |
| 08/03/1994 | EP0608433A1 Composition for dermatologic preparation |
| 08/03/1994 | EP0608322A1 Enhanced skin penetration system for improved topical delivery of drugs |
| 08/03/1994 | EP0608320A1 Enhanced skin penetration system for improved topical delivery of drugs |
| 08/03/1994 | CN1090277A Benzoxazinones as inhibitors of HIV reverse transcriptase |
| 08/03/1994 | CN1090126A Quick-drying gel-type disinfectant for hands and fingers |
| 08/02/1994 | US5334138 Drug delivery; mixture of active material and vasoconstrictor |
| 08/02/1994 | CA1331140C Agents for preserving or restoring the soundness of the skin |
| 08/02/1994 | CA1331139C Medicaments for the treatment of cerebral apoplexy |
| 08/02/1994 | CA1331138C Use of reverse transcriptase inhibitor for treatment of human breast carcinoma |
| 08/02/1994 | CA1331132C Method of treatment for non-specific inflammation |
| 07/28/1994 | DE4301739A1 Treatment of primary tumours and viral diseases |
| 07/27/1994 | EP0607353A1 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 07/27/1994 | EP0607278A1 Method for enhancing gut absorption |
| 07/27/1994 | EP0414816B1 Induction of tolerance to a foreign antigen |
| 07/27/1994 | EP0191771B1 Automatic injector assembly |
| 07/21/1994 | WO1994016109A1 Membrane fusion events and means for altering same |
| 07/21/1994 | WO1994016059A1 Method for production of neuroblasts |
| 07/21/1994 | WO1994015966A1 Growth differentiation factor-9 |
| 07/21/1994 | WO1994015949A1 Growth differentiation factor-5 |
| 07/21/1994 | WO1994015642A1 Methods of delivering agents to target cells |
| 07/21/1994 | WO1994015629A1 Method for treating myofascial pain syndrome |
| 07/21/1994 | WO1994015615A1 Potentiation of temozolomide in human tumour cells |
| 07/21/1994 | WO1994015613A1 Use of cyclooxygenase inhibitors for the manufacture of a medicament for enhancing uterine blood perfusion |
| 07/21/1994 | WO1994015598A2 Methods for the improvement of cognition with functional antagonists of the glycine nmda receptor complex |
| 07/21/1994 | WO1994015592A1 Compositions comprising cholesterol lowering agents and antioxidants |
| 07/21/1994 | WO1994015488A2 Rehydration drink |
| 07/21/1994 | WO1994012639A3 Interleukin-3 (il-3) mutant polypeptides |
| 07/21/1994 | WO1994007479A3 Immunopotentiatory agents |
| 07/21/1994 | CA2153781A1 Method for treating myofascial pain syndrome |
| 07/21/1994 | CA2153654A1 Growth differentiation factor-5 |
| 07/21/1994 | CA2153596A1 Methods for the improvement of cognition with functional antagonists of the glycine nmda receptor complex |
| 07/21/1994 | CA2153568A1 Methods of delivering agents to target cells |
| 07/21/1994 | CA2152597A1 Method for production of neuroblasts |
| 07/20/1994 | EP0606219A1 Wound cleanser |
| 07/20/1994 | EP0606217A1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 07/19/1994 | US5331003 Anticoccidial methods |
| 07/19/1994 | US5330972 Method of impeding apoptosis of CD4 cells in persons infected with human immunodeficiency virus |
| 07/19/1994 | CA1330759C Method for the treatment of gastro intestinal disorders |
| 07/13/1994 | EP0605501A1 Method and compositions for the treatment of cerebral palsy |
| 07/13/1994 | EP0327640B1 Immunotherapeutic compositions for the treatment of acquired immune deficiency syndrome |
| 07/12/1994 | US5328955 Using a hydrophilic polyethylene |
| 07/12/1994 | US5328686 Treatment of acne or of pseudofolliculitis barbae |
| 07/07/1994 | WO1994015211A1 Improved methods for the determination and adjustment of prolactin daily rhythms |
| 07/07/1994 | WO1994014956A1 Molecular flashlight |
| 07/07/1994 | WO1994014476A1 Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders |
| 07/07/1994 | WO1994014473A1 Therapeutic combination containing interferon |
| 07/07/1994 | WO1994014467A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 07/07/1994 | WO1994014448A1 Novel combination of benzoquinazoline antifolates and protecting agents |
| 07/07/1994 | WO1994014436A1 Retroviral protease inhibiting compounds |
| 07/07/1994 | WO1994014433A1 COMBINATION OF A CHOLESTEROL BIOSYNTHESIS INHIBITOR AND A β-LACTAM CHOLESTEROL ABSORPTION INHIBITOR |
| 07/07/1994 | WO1994014341A1 Medical foods for the nutritional support of child/adult metabolic diseases |
| 07/07/1994 | CA2152508A1 Improved methods for the determination and adjustment of prolactin daily rhythms |
| 07/07/1994 | CA2152389A1 Therapeutic combination containing interferon |
| 07/07/1994 | CA2151912A1 Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders |